In vivo gene delivery mediated by non-viral vectors for cancer therapy

J Control Release. 2020 Sep 10:325:249-275. doi: 10.1016/j.jconrel.2020.06.038. Epub 2020 Jul 4.

Abstract

Gene therapy by expression constructs or down-regulation of certain genes has shown great potential for the treatment of various diseases. The wide clinical application of nucleic acid materials dependents on the development of biocompatible gene carriers. There are enormous various compounds widely investigated to be used as non-viral gene carriers including lipids, polymers, carbon materials, and inorganic structures. In this review, we will discuss the recent discoveries on non-viral gene delivery systems. We will also highlight the in vivo gene delivery mediated by non-viral vectors to treat cancer in different tissue and organs including brain, breast, lung, liver, stomach, and prostate. Finally, we will delineate the state-of-the-art and promising perspective of in vivo gene editing using non-viral nano-vectors.

Keywords: Cancer; Clinical translation; Gene delivery; Gene editing; Non-viral vectors; in vivo.

Publication types

  • Review

MeSH terms

  • Gene Transfer Techniques
  • Genetic Therapy
  • Genetic Vectors*
  • Humans
  • Male
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • Polymers

Substances

  • Polymers